Moreover, in cross-sectional studies, it has also been shown that FGF-21 concentration is elevated in patients suffering from obesity, T2DM, metabolic syndrome, and nonalcoholic fatty liver disease [10–13]. Here, FGF21 is linked to obesity due to melanocortin 4 receptor deficiency.